First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy

NCT06667167 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

NSCLC (non-small Cell Lung Cancer)

Interventions

DRUG: Induction Carboplatin

Sponsor

Nir Peled